Get inspired and join us in Baltimore, Maryland on September 21-23, for the 2009 World Stem Cell Summit 2009 CONFERENCE OVERVIEW Creating a winning strategy entails understanding the complexities and moves of the all research and industry stakeholders.  The World Stem Cell Summit provides the 360-degree view of this burgeoning field while delivering focused and in-depth science, business and industry insight with unsurpassed networking and partnering opportunities. 2009 World Stem Cell Summit Program Overview: Science:  28 compelling science presentations from leading biologist, tissue engineers and nanotechnologists.  Topics cover Human Embryonic Stem Cells, Induced Pluripotent Stem Cells; Nanotechnology and Bioengineering; Stem Cells and Disease Modeling; Neural Stem Cell; Cardiac; Cancer Stem Cell; Mesenchymal and Hematopoietic Stem Cells and Research Funding Opportunities Business & Law:  Key Technologies of the ReGEN Industry; The Role of Big Pharma, Big Biotech, Big Device; Regulatory and Reimbursement Strategies; Commercialization, International Alliances, Partnerships and Acquisitions, Advanced Intellectual Property Issues, International Market Trends, Licensing, Technology Transfer, Successful Business Models Innovative Funding Mechanisms and more. Medicine: Five Disease focus sessions designed for physicians and other healthcare providers. Sessions Cover Spinal Cord Injury and Multiple Sclerosis; Cancer; Cardiovascular; Diabetes; Blindness, Aging and Rare Diseases; Parkinson’s / ALS / Neurological Disorders.  Each panel features a clinician, industry representative, scientist, consumer and foundation representative International Discussions: International Strategies, Partnerships and Collaborations; Stem Cells and the Potential for National and Regional Economic Development; Stem Cells in Clinical Treatments and Medical Tourism; International Standards and Regulations; Regenerative Medicine for Wounded Soldiers; Case Study on Maryland’s Investment in Stem Cell Science;  Cord Blood and Cell Banking and more Ethics and Advocacy:  Stem Cell Action—A New Agenda for Advocates, Ethics and Societal Issues, Understanding Federal Policy, Drug Development Timelines and Medical Tourism Concerns and Guidelines Conference Organizers and Introduction: Presented by the Genetics Policy Institute, the 2009 Summit is hosted by Johns Hopkins University, the University System of Maryland, Maryland Department of Business and Economic Development, Maryland Technology Development Corporation and Maryland Stem Cell Research Fund. The World Stem Cell Summit is the flagship event, bringing together the founding visionary researchers, clinicians, business pathfinders, key policy-makers, regulators, advocates, experts in law and ethics to present compelling presentations, share information, and together chart the future of regenerative medicine. Conference Co-Chairs: Curt Civin, University of Maryland; Chi Dang, Johns Hopkins University; Linda Powers, Toucan Capital Inc.; Karen Rothenberg, Maryland Stem Cell Research Commission; Bernard Siegel, Genetics Policy Institute. Conference History: The 2009 World Stem Cell Summit marks the fifth annual summit presented by the Genetics Policy Institute. Past event partners include: University of Wisconsin-Madison Stem Cell & Regenerative Medicine Center, WiCell Research Institute, Harvard Stem Cell Institute, Stanford University, Baylor College of Medicine and the United Nations. The 2008 summit attracted attendees from 25 states and 17 countries. Conference Topics: 2009 panel discussions will focus on the science, business, policy, law and ethics of all stem cell types including human embryonic stem cells, adult stem cells and induced pluripotent stem cells. To maximize the potential of stem cell research, the 2009 World Stem Cell Summit program is designed to cover the field’s most pressing topics including: progressive research strategies, translational and preclinical findings, cross disciplinary initiatives, drug discovery, funding opportunities (federal, public and private), commercialization plans, technology transfer platforms, venture capital insight, market trends, regulatory issues, ethical and societal implications, philanthropic opportunities, medical tourism challenges, cell banking projects, intellectual property landscapes, insurance questions, international perspectives, clinical use and the 2009-10 advocacy agenda. New for 2009: The 2009 Summit will feature an advanced science track featuring some of the world's most prominent scientists addressing the latest discoveries in basic research, translational and preclinical findings, bioengineering and cellular scaffold initiatives, clinical trials updates, and an in depth look at the pharmaceutical industry's short term and long term vision for stem cells. For the first time the Summit’s educational program will be jointly sponsored by University of Maryland School of Medicine for AMA_PRA Category 1 Credit. Lastly, the 2009 Summit will feature several economic development panels designed to enhance states and nations economic strategies and opportunities for constructive collaborations. Conference Attendees: We anticipate the 2009 World Stem Cell Summit to attract more than 1,200 of the world’s most influential stem cell stakeholders in science, business, policy, law, ethics and advocacy. Additionally, 100 plus internationally renowned speakers will be present—producing a unique international network designed to foster collaborations, economic development, technology transfer, commercialization, private investment and philanthropy. Conference Exhibitors: Sixty world leading stem cell companies, organizations, states and nations will showcase cutting edge products, research breakthroughs, investment strategies and government initiatives to advance this burgeoning field. Exhibit spaces are limited and strategically positioned to maximize traffic and awareness. Exhibit spaces are reserved on a first come first serve basis purchase your space today. Don't miss this opportunity. Space is limited, so register now!  Sponsor and exhibit opportunities are now available. Contact Alan Fernandez to learn more.